195 related articles for article (PubMed ID: 3756873)
1. Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristics.
Fradet Y; Cordon-Cardo C; Whitmore WF; Melamed MR; Old LJ
Cancer Res; 1986 Oct; 46(10):5183-8. PubMed ID: 3756873
[TBL] [Abstract][Full Text] [Related]
2. Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Laval University Urology Group.
Fradet Y; Tardif M; Bourget L; Robert J
Cancer Res; 1990 Jan; 50(2):432-7. PubMed ID: 2295082
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies raised against cell membrane components of human bladder tumor tissue recognizing subpopulations in normal urothelium.
Summerhayes IC; McIlhinney RA; Ponder BA; Shearer RJ; Pocock RD
J Natl Cancer Inst; 1985 Dec; 75(6):1025-38. PubMed ID: 2415743
[TBL] [Abstract][Full Text] [Related]
4. Growth-regulated surface glycoproteins of human bladder cancer.
Gauthier J; Fradet Y
Cancer Res; 1990 Jan; 50(2):293-8. PubMed ID: 2403838
[TBL] [Abstract][Full Text] [Related]
5. Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.
Fradet Y; Cordon-Cardo C; Thomson T; Daly ME; Whitmore WF; Lloyd KO; Melamed MR; Old LJ
Proc Natl Acad Sci U S A; 1984 Jan; 81(1):224-8. PubMed ID: 6364135
[TBL] [Abstract][Full Text] [Related]
6. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium.
Ben-Aïssa H; Paulie S; Gustafsson B; Håkansson L; Lagerkvist M; Gustafson H; Ahlstrand C; Perlmann P
Anticancer Res; 1988; 8(3):443-9. PubMed ID: 3389746
[TBL] [Abstract][Full Text] [Related]
7. Effect of intravesical Bacillus Calmette-Guérin on detection of a urothelial differentiation antigen in exfoliated cells of carcinoma in situ of the human urinary bladder.
Huffman JL; Fradet Y; Cordon-Cardo C; Herr HW; Pinsky CM; Oettgen HF; Old LJ; Whitmore WF; Melamed MR
Cancer Res; 1985 Oct; 45(10):5201-4. PubMed ID: 4027997
[TBL] [Abstract][Full Text] [Related]
8. Production and characterization of mouse monoclonal antibodies to human bladder tumor-associated antigens.
Young DA; Prout GR; Lin CW
Cancer Res; 1985 Sep; 45(9):4439-46. PubMed ID: 3896480
[TBL] [Abstract][Full Text] [Related]
9. Scanning electron microscopy of immuno-gold labeled antigens associated with bladder cancer.
de Harven E; Connolly JG; Wang Y; Hanna W; Bootsma G
Scanning Microsc; 1990 Jun; 4(2):467-76; discussion 476-7. PubMed ID: 2402614
[TBL] [Abstract][Full Text] [Related]
10. Human bladder cancer cell-surface antigens recognized by murine monoclonal antibodies raised against T24 bladder cancer cells.
Masuko T; Abe J; Yagita H; Hashimoto Y
Jpn J Cancer Res; 1985 May; 76(5):386-94. PubMed ID: 3924712
[TBL] [Abstract][Full Text] [Related]
11. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells.
Masuko T; Yagita H; Hashimoto Y
J Natl Cancer Inst; 1984 Mar; 72(3):523-30. PubMed ID: 6583438
[TBL] [Abstract][Full Text] [Related]
13. Blood group-related antigens in human urothelium: enhanced expression of precursor, LeX, and LeY determinants in urothelial carcinoma.
Cordon-Cardo C; Reuter VE; Lloyd KO; Sheinfeld J; Fair WR; Old LJ; Melamed MR
Cancer Res; 1988 Jul; 48(14):4113-20. PubMed ID: 2454735
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to cell surface antigens shared by chemically induced mouse bladder carcinomas.
Hellström I; Hellström KE; Rollins N; Lee VK; Hudkins KL; Nepom GT
Cancer Res; 1985 May; 45(5):2210-8. PubMed ID: 3986770
[TBL] [Abstract][Full Text] [Related]
15. [Molecular changes in development and progression of urothelial carcinoma].
Hartmann A
Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
[TBL] [Abstract][Full Text] [Related]
16. Molecular pathways of urothelial development and bladder tumorigenesis.
Castillo-Martin M; Domingo-Domenech J; Karni-Schmidt O; Matos T; Cordon-Cardo C
Urol Oncol; 2010; 28(4):401-8. PubMed ID: 20610278
[TBL] [Abstract][Full Text] [Related]
17. Blood group antigens in transitional cell tumours of the urinary bladder. An immunohistochemical study.
Juhl BR
Dan Med Bull; 1994 Feb; 41(1):1-11. PubMed ID: 8187557
[TBL] [Abstract][Full Text] [Related]
18. Identification by monoclonal antibodies of an antigen shed by human bladder cancer cells.
Liebert M; Wedemeyer GA; Stein JA; Washington RW; Flint A; Ren LQ; Grossman HB
Cancer Res; 1989 Dec; 49(23):6720-6. PubMed ID: 2479470
[TBL] [Abstract][Full Text] [Related]
19. Immunopathologic analysis of human urinary bladder cancer. Characterization of two new antigens associated with low-grade superficial bladder tumors.
Cordon-Cardo C; Wartinger DD; Melamed MR; Fair W; Fradet Y
Am J Pathol; 1992 Feb; 140(2):375-85. PubMed ID: 1739131
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies against carcinoma cells of the human urinary bladder: immunohistochemical staining of tissues.
Ben-Aïssa H; Paulie S; Koho H; Biberfeld P; Hansson Y; Braesch-Andersen S; Lagerkvist M; Lundblad ML; Gustafson H; Perlmann P
Anticancer Res; 1986; 6(2):165-70. PubMed ID: 2423013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
